Search Results for "morcellator"
- Aetna to No Longer Cover Routine Morcellator Procedures
According to Nasdaq, the American health insurance company Aetna, Inc., will no longer cover routine procedures involving laparoscopic power morcellators. Aetna provides the nation’s third largest health care plan, with roughly 23 million members, and its decision not to cover routine morcellator ...
- Senators Call for Further Action on Power Morcellators Amid FDA Concern
Two U.S. senators, Charles Schumer and Kirsten Gillibrand have stepped forward to request further FDA action to regulate the use of power morcellators. An article in Modern Healthcare documents the growing debate over whether to end completely or restrict the use of laparoscopic power morcellators.
...
- Johnson & Johnson Alerted to Morcellator Cancer Risk in 2006
A report published in the Pittsburgh Business Times indicates that the Johnson & Johnson subsidiary responsible for manufacturing power morcellators was warned eight years ago that their device could increase the risk of spreading cancer. The news is based on a series of communications between ...
- Power Morcellator Cancer Lawsuit
The US FDA has issued a warning about use of power morcellators—devices used in certain laparoscopic operations, including hysterectomy and myomectomy to treat uterine fibroids in women. When used on a patient with an unsuspected or undiagnosed uterine cancer, power morcellators can cause the spre...
- Ethicon Recalls Surgical Stapler
Johnson & Johnson’s Ethicon medical device division has recalled a line of surgical staplers over concerns that a part within the jawed hinge of the device may cause staples to be formed improperly. The units are from the Echelon Flex Endopath line and come in a variety of lengths. Echelon Fle...
- Another Johnson & Johnson Unit, Another Recall
While Johnson & Johnson might be a household name, the names of its subsidiary units are a bit less well known. Names like Ethicon and DePuy fly under the radar for all but those that have been negatively affected by their products’ defects while Johnson & Johnson remains known as the make...
- Deal Between FDA, Medical Device Makers Could Put Consumers At Risk
Congress is planning to vote on a deal between the medical device industry and the FDA that could come at great risk to consumers, according to the New York Times. The agreement between the two parties is renegotiated every five years and focuses heavily on the fees that medical device companies pay...
- Ethicon Pulls Another Device Off the Market
Ethicon’s decision to pull its Physiomesh surgical mesh off the market earlier this year is just one more in a string of failures for the medical device unit of Johnson & Johnson. The decision comes from mounting evidence of a higher number of revision surgeries associated with Physiomesh than...
